Astrazeneca buys into arthritis drug (the news journal)

2010-02-17 | Source

AstraZeneca Plc bought rights to Rigel Pharmaceuticals Inc's experimental arthritis treatment, throwing a lifeline to a drug that failed in a clinical trial last year.